Chelation therapy, What is it? (this is my alternative treatment)

Conventional medicine has been using various intravenous chelation approaches since deployed troops were poisoned with the heavy metal arsenic during the First World War. Coined from the Greek chelè, meaning claw — to reflect their capacity to bind metals within a “claw-like” molecular structure, which is then excreted without further interaction with the body — the first medically-used chelating agent was developed at the start of WWII as an antidote to anticipated use of arsenic gas by the Germans. Today, chelation therapy is the recognized, U.S. Food and Drug Administration approved, medical treatment for heavy metal intoxication by lead, cadmium, aluminum, mercury, arsenic, and even iron.
Despite decades of medical use in response to large-scale heavy metal exposures along with overwhelming scientific rationale and evidence, chelation therapy is often overlooked as a solution to the adverse health effects caused by more gradual build-up of toxic metals.
Why? you ask. There are a number of reasons:
- Because most exposures are not large-scale, occuring gradually at low levels from living in industrialized nations, for most of us the exact cause of our symptoms is hard to pin-point, or our symptoms are subtle, or we may not have symptoms but are trying to prevent disease from occuring.
- Subtle symptoms, or worse, diseases one is trying to prevent, are very, very difficult to study. This makes FDA approval for use with chronic degenerative diseases difficult (and very costly) as supporting research must show cause and effect. Keep in mind that chelation therapy is approved for use when someone has a known heavy metal exposure.
Ever-increasing use and accumulation of pollutants in general, and persistant organic pollutants in particular, have received recent attention for their long-lasting adverse health effects. Gradual exposure to hazardous toxins is becoming more prevalent especially in overpopulated and industrialized parts of the world. Such exposure contributes to increased health risks. Unfortunately, there is no easy fix to protect or intervene against diseases associated with exposure to these insidious environmental pollutants. Many pollutants, including heavy metals and persistent organics, bioaccumulate (pass up the food chain to humans) and build up in our bodies where they cause damage both locally to the tissues where they accumulate, including contributing to the formation of cancer, vascular disease, accelerated aging as well as altering the normal patterns of hormones — patterns that effect everything from energy level to fertility to mood. Exposure to heavy metals can occur via many common sources: house paint (lead), dental fillings (mercury), vaccines (mercury), cigarettes (cadmium), food, drinking water and hazardous waste sites.

Getting rid of unwanted contaminants.
Many doctors argue — have argued for decades — that chelation therapy can address low level metal exposures and consequent degenerative diseases. Recent understanding of how pollution contributes to the formation of blocked heart arteries, by contributing contaminants — inflammation-causing molecules known as “free radicals” — many of which are heavy metals, has lead to investment in large-scale clinical trials to gather more data on the effectiveness of chelation therapy to treat our number one killer, heart disease.

Effective chelation therapy is administered in I.V. EDTA form over the course of several hours. Effective chelation therapy depends on whether the chelating agents are able to remove heavy metals that are circulating in the blood or deposited in cells in the body — the chelator must get into the blood and cells. IV chelation agents effect the build-up of calcium, iron, or copper within the cells – a build-up that can lead to stiffening and hardening of tissues and other degenerative diseases.